Clinical Study
Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy
Table 1
Changes in DAS28, CRP, and ultrasonography data in 34 patients undergoing anti-TNF-alpha-adalimumab therapy due to RA refractory to conventional DMARDs.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(FMD: flow-mediated endothelium dependent vasodilatation; NTG: flow-mediated endothelium independent vasodilatation; IMT: intima-media thickness; CRP: C-reactive protein). |